Circulating T Lymphocyte Subsets, Cytokines, and Immune Checkpoint Inhibitors in Patients with Bipolar II or Major Depression: a Preliminary Study
Wei Wu,Ya-li Zheng,Li-ping Tian,Jian-bo Lai,Chan-chan Hu,Peng Zhang,Jing-kai Chen,Jian-bo Hu,Man-li Huang,Ning Wei,Wei-juan Xu,Wei-hua Zhou,Shao-jia Lu,Jing Lu,Hong-li Qi,Dan-dan Wang,Xiao-yi Zhou,Jin-feng Duan,Yi Xu,Shao-hua Hu
DOI: https://doi.org/10.1038/srep40530
2019-01-01
Abstract:This study aimed to investigate the less known activation pattern of T lymphocyte populations and immune checkpoint inhibitors on immunocytes in patients with bipolar II disorder depression (BD) or major depression (MD). A total of 23 patients with BD, 22 patients with MD, and 20 healthy controls (HCs) were recruited. The blood cell count of T lymphocyte subsets and the plasma level of cytokines (IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ) were selectively investigated. The expression of T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), programmed cell death protein 1 (PD-1) and its ligands, PD-L1 and PD-L2, on T lymphocytes and monocytes, was detected. In results, blood proportion of cytotoxic T cells significantly decreased in BD patients than in either MD patients or HCs. The plasma level of IL-6 increased in patients with BD and MD. The expression of TIM-3 on cytotoxic T cells significantly increased, whereas the expression of PD-L2 on monocytes significantly decreased in patients with BD than in HCs. These findings extended our knowledge of the immune dysfunction in patients with affective disorders.